These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 35370989)

  • 1. Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement.
    Wan XX; Zhang DY; Khan MA; Zheng SY; Hu XM; Zhang Q; Yang RH; Xiong K
    Front Endocrinol (Lausanne); 2022; 13():859638. PubMed ID: 35370989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
    Dadheech N; James Shapiro AM
    Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Original hypothesis: Extracorporeal shockwaves as a homeostatic autoimmune restorative treatment (HART) for Type 1 diabetes mellitus.
    Craig K; d'Agostino C; Poratt D; Walker M
    Med Hypotheses; 2014 Sep; 83(3):250-3. PubMed ID: 24947195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapy for type 1 diabetes: autologous hematopoietic stem cell transplantation.
    Li L; Gu W; Zhu D
    J Diabetes; 2012 Dec; 4(4):332-7. PubMed ID: 23190701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Bioluminescence for the Detection of the Fate of Pancreatic Islet Organoids Post-transplantation.
    Sun A; Kenyon E; Gudi M; Li W; Aguirre A; Wang P
    Methods Mol Biol; 2023; 2592():195-206. PubMed ID: 36507995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hTIMP-1 overexpression in human umbilical cord mesenchymal stem cells on the repair of pancreatic islets in type-1 diabetic mice.
    Bao Y; Zhao Z; Gao H
    Cell Biol Int; 2021 May; 45(5):1038-1049. PubMed ID: 33404139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durable Control of Autoimmune Diabetes in Mice Achieved by Intraperitoneal Transplantation of "Neo-Islets," Three-Dimensional Aggregates of Allogeneic Islet and "Mesenchymal Stem Cells".
    Westenfelder C; Gooch A; Hu Z; Ahlstrom J; Zhang P
    Stem Cells Transl Med; 2017 Jul; 6(7):1631-1643. PubMed ID: 28467694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
    Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus.
    Vanikar AV; Trivedi HL; Thakkar UG
    Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.
    Jun Y; Kang AR; Lee JS; Park SJ; Lee DY; Moon SH; Lee SH
    Biomaterials; 2014 Jun; 35(17):4815-26. PubMed ID: 24636217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current progress in stem cell therapy for type 1 diabetes mellitus.
    Chen S; Du K; Zou C
    Stem Cell Res Ther; 2020 Jul; 11(1):275. PubMed ID: 32641151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Encapsulation and Delivery Strategies for Islet Transplantation.
    Wu S; Wang L; Fang Y; Huang H; You X; Wu J
    Adv Healthc Mater; 2021 Oct; 10(20):e2100965. PubMed ID: 34480420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell applications in diabetes.
    Noguchi H
    J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress on the donor cell sources of pancreatic islet transplantation for treatment of diabetes mellitus].
    Zhu H; Zhang X; He Y; Yu L; Lü Y; Pan K; Wang B; Chen G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 Jan; 32(1):104-111. PubMed ID: 29806374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.
    Rahavi H; Hashemi SM; Soleimani M; Mohammadi J; Tajik N
    J Diabetes Res; 2015; 2015():878535. PubMed ID: 25893202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell Therapy for the Management of Type 1 Diabetes: Advances and Perspectives.
    Goyal P; Malviya R
    Endocr Metab Immune Disord Drug Targets; 2024; 24(5):549-561. PubMed ID: 37861029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Therapy and Type 1 Diabetes Mellitus: Treatment Strategies and Future Perspectives.
    Farooq T; Rehman K; Hameed A; Akash MSH
    Adv Exp Med Biol; 2019; 1084():95-107. PubMed ID: 29896720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential roles of mesenchymal stromal cells in islet allo- and xenotransplantation for type 1 diabetes mellitus.
    Qu Z; Lou Q; Cooper DKC; Pu Z; Lu Y; Chen J; Ni Y; Zhan Y; Chen J; Li Z; Zhan N; Zeng Y; Tu Z; Cao H; Dai Y; Cai Z; Mou L
    Xenotransplantation; 2021 May; 28(3):e12678. PubMed ID: 33569837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet Microencapsulation: Strategies and Clinical Status in Diabetes.
    Omami M; McGarrigle JJ; Reedy M; Isa D; Ghani S; Marchese E; Bochenek MA; Longi M; Xing Y; Joshi I; Wang Y; Oberholzer J
    Curr Diab Rep; 2017 Jul; 17(7):47. PubMed ID: 28523592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Differentiation of Stem Cell-derived Human Pancreatic Progenitors to Treat Type 1 Diabetes.
    Maloy MH; Ferrer MA; Parashurama N
    Stem Cell Rev Rep; 2020 Dec; 16(6):1139-1155. PubMed ID: 32844324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.